ArticleJAMA network open2022

Appraising Drugs Based on Cost-effectiveness and Severity of Disease in Norwegian Drug Coverage Decisions.

Eirik Joakim Tranvåg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.